Irrational polypharmacy and potentially inappropriate medications in patients with dementia: Treatment strategies

Abstract Most patients with dementia are treated irrational polypharmacy, which leads to higher mortality and other negative consequences (higher costs). Nearly 50% of elderly take one or more medications that not medically necessary, represents another important aspect medication optimization. Research has established a strong relationship between polypharmacy its clinical consequences, including impact on dementia, especially in excessive (10 medications). These underrepresented the treatment guidelines randomized controlled trials, although they represent substantial patient population. The burden also been associated greater risk adverse drug events, drug-drug interactions, non-adherence potentially inappropriate (PIM) use. Different strategies have available reduce this best intervention for reduction population involves an inter-professional approach (collaborative care approach) often includes special tools, basic pharmacological collaboration pharmacist. Disclosure Interest None Declared